Kenneth Ferguson
Director/Miembro de la Junta en CYCLACEL PHARMACEUTICALS, INC. .
Fortuna: 6 200 $ al 30/04/2024
Origen de la red de primer grado Kenneth Ferguson.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.
37
| Holding Company | Investment Managers | 37 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.
28
| Subsidiary | Pharmaceuticals: Other | 28 |
Public Company | Pharmaceuticals: Major | 14 | |
Public Company | Pharmaceuticals: Major | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Kenneth Ferguson a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal Founder Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Doctorate Degree | |
ALSP ORCHID ACQUISITION CORPORATION I | Financial Conglomerates | Director of Finance/CFO Chairman Chief Executive Officer Corporate Officer/Principal Director/Board Member Investor Relations Contact Chief Operating Officer Corporate Officer/Principal Director/Board Member Director/Board Member | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Founder Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Doctorate Degree | |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer General Counsel | |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder Founder Corporate Officer/Principal | |
Acylin Therapeutics, Inc.
Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Director/Board Member | |
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer | |
Princeton University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
University of Kansas | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder Director/Board Member | |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Corporate Officer/Principal | |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Founder Director/Board Member | |
Washington State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Private Equity Investor General Counsel | |
ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
Cerevast Medical, Inc.
Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Investment Managers | Director/Board Member Chief Executive Officer | |
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Corporate Officer/Principal | |
ISB Accelerator Corp.
ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Miscellaneous Commercial Services | President Chief Executive Officer | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
MACROGENICS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Providence Health & Services
Providence Health & Services Medical/Nursing ServicesHealth Services Providence Health & Services provides healthcare services. It offers assisted and independent living; express care; hospice and home health care; hospitals and medical centers; nursing homes and traditional care; PACE and adult day programs; providence medical group; and supportive housing. The company was founded in 1859 and is headquartered Renton, WA. | Medical/Nursing Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | Investment Managers | Investment Committee Member Investment Committee Member | |
University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
University of British Columbia | College/University | Doctorate Degree Doctorate Degree | |
SHIRE | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Estadísticas
Internacional
Estados Unidos | 49 |
Canadá | 2 |
Irlanda | 2 |
Sectorial
Health Technology | 29 |
Consumer Services | 12 |
Commercial Services | 7 |
Finance | 5 |
Health Services | 2 |
Operativa
Director/Board Member | 451 |
Corporate Officer/Principal | 204 |
Independent Dir/Board Member | 92 |
Founder | 78 |
Chairman | 72 |
Las relaciones más conectadas
Insiders | |
---|---|
Steven Gillis | 58 |
Joel Marcus | 57 |
Leroy Hood | 34 |
Robert Spiegel | 30 |
Thong Le | 30 |
Robert W. Pangia | 26 |
Bruce Carter | 25 |
Dan Spiegelman | 24 |
Wendy Johnson | 23 |
Sundar Kodiyalam | 21 |
Jan Lundberg | 21 |
Jean-Philippe Tripet | 20 |
Rajiv J. Shah | 20 |
Paul Clark | 19 |
Leslie Williams | 19 |
- Bolsa de valores
- Insiders
- Kenneth Ferguson
- Conexiones Empresas